Table 4.

Completeness of VL measures and number (percentage) of patients virally suppressed^a in their last year of follow-up, by gender and calendar period of ART initiation.

	Calendar period of ART initiation
	2004–2006		2007–2009		2010–2012		2013–2015		Total
Patients (n)
All	11,243		19,148		27,516		14,905		72,812
Males	3537		6531		8974		4745		23,787
Females	7706		12,617		18,542		10,160		49,025
VL measures, n (%)
All	8594	76%	14,531	76%	20,337	74%	10,583	71%	54,045	74%
Males	2593	73%	4791	73%	6356	71%	3279	69%	17,019	72%
Females	6001	78%	9740	77%	13,981	75%	7304	72%	37,026	76%
Virally suppressedb, n (%)
All	7267	85%	12,056	83%	17,946	88%	9406	89%	46,675	86%
Males	2136	82%	3804	79%	5413	85%	2854	87%	14,207	83%
Females	5131	86%	8252	85%	12,533	90%	6552	90%	32,468	88%

^aViral suppression: viral load <1000 copies/mL.

^bOf those with viral load measures, percentage with viral load <1000 copies/mL.